Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...

The FDA, in a stark reversal, on Friday said it would reconsider its decision to remove Eli Lilly’s tirzepatide from its ...

There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.

Some patients fear that they’ll lose access to tirzepatide because the US Food and Drug Administration determined that a ...

Even though there is no official Ozempic Diet, there are certain foods you can avoid to minimize your chances of negative ...

The FDA has approved Cobenfy, the first new type of schizophrenia drug in decades. Cobenfy doesn’t appear to have the same severe side effects as older antipsychotic medicines — like weight ...

The FDA has removed two of Eli Lilly's in-demand weight-loss and diabetes drugs from its shortage list. Diabetes drug ...

Originally approved to help with excess weight and obesity, the injectable Wegovy and its sibling-product Ozempic, which is ...

For the first time in nearly three decades, a new treatment for schizophrenia has been approved by the U.S. Food and Drug Administration (FDA). On September 26, the FDA gave the green light to ...

The U.S. Food and Drug Administration (FDA) has approved Dupixent (dupilumab) injections as an add-on therapy for certain adults with poorly controlled chronic obstructive pulmonary disease (COPD).

“It’s not even a needle in a haystack, it’s kind of like a needle in a stack of needles.” Dr. James Lawler, of the University of Nebraska’s Global Center for Health Security, on trying ...

A new drug has been approved for the treatment of schizophrenia in adults. On Thursday, the U.S. Food and Drug Administration (FDA) approved COBENFY (xanomeline and trospium chloride), an oral ...